Lotrafiban structure
|
Common Name | Lotrafiban | ||
|---|---|---|---|---|
| CAS Number | 171049-14-2 | Molecular Weight | 428.52500 | |
| Density | 1.22g/cm3 | Boiling Point | 730ºC at 760 mmHg | |
| Molecular Formula | C23H32N4O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 395.3ºC | |
Use of LotrafibanLotrafiban is an orally-active platelet GPIIb/IIIa blocker for treatment of coronary and cerebrovascular disease. |
| Name | 2-[(2S)-4-methyl-3-oxo-7-(4-piperidin-4-ylpiperidine-1-carbonyl)-2,5-dihydro-1H-1,4-benzodiazepin-2-yl]acetic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Lotrafiban is an orally-active platelet GPIIb/IIIa blocker for treatment of coronary and cerebrovascular disease. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.22g/cm3 |
|---|---|
| Boiling Point | 730ºC at 760 mmHg |
| Molecular Formula | C23H32N4O4 |
| Molecular Weight | 428.52500 |
| Flash Point | 395.3ºC |
| Exact Mass | 428.24200 |
| PSA | 101.98000 |
| LogP | 2.10820 |
| Vapour Pressure | 2.27E-22mmHg at 25°C |
| Index of Refraction | 1.572 |
| InChIKey | PYZOVVQJTLOHDG-FQEVSTJZSA-N |
| SMILES | CN1Cc2cc(C(=O)N3CCC(C4CCNCC4)CC3)ccc2NC(CC(=O)O)C1=O |
| Lotrafiban |